PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Health Evaluation and Promotion0 citationsOpen Access

Cytology and High-risk HPV Test in Cervical Cancer Screening in Our Hospital from 2021 to 2023

MSMasatoshi SuzukiRWRyuichi WadaAIAkari Ichikawa

Key Points

  • The aim is to analyze cytology and high-risk HPV test results for cervical cancer screening over three years.
  • Collected data from cytology tests conducted from 2021 to 2023.
  • Included results from accompanying high-risk HPV tests.
  • Conducted analysis of the findings to provide insights.
  • Cytology and hrHPV results were systematically compiled.
  • Insights into the effectiveness of screening methods were discussed.

Abstract

【目的】当院では子宮頸がん検診を細胞診単独法で行っており、希望者はhigh risk HPV（hrHPV）検査を受けることが可能である。2021年から3年間の細胞診判定とhrHPV検査結果を集計し、考察を加えた。

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Suzuki et al. (2026) studied this question.

synapsesocial.com/papers/69994bdd873532290d01fe3bhttps://doi.org/10.7143/jhep.2025-58
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1822 High grade cervical lesions in women with non 16–18 high-risk human papillomavirus2024
  2. 2Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis2024
  3. 3Prevalence and distribution of high-risk HPV in an organized hospital-based cervical cancer screening cohort2026
  4. 4Human Papillomavirus Genotype Detection and Cytology Using a New Self-Sampling Method2024 · 1 citations
  5. 5Risk-Based Triage Using Cytology and HPV Genotyping to Reduce Unnecessary Colposcopy: A Real-World Cross-Sectional Study2026